Amodiaquine, sulfadoxine/pyrimethamine, and combination therapy for treatment of uncomplicated falciparum malaria in Kampala, Uganda: A randomised trial

Lancet

Volumn 358, Issue 9279, 2001, Pages 368-374

  Staedke, Sarah G ^a   Kamya, Moses R ^b   Dorsey, Grant ^a   Gasasira, Anne ^b   Ndeezi, Grace ^b   Charlebois, Edwin D ^a,c   Rosenthal, Philip J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MAKERERE UNIVERSITY MEDICAL SCHOOL   (Uganda)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE; ANTHELMINTIC AGENT; ANTIMALARIAL AGENT; FANSIDAR; FERROUS SULFATE; PARACETAMOL; PLACEBO;

ADOLESCENT; AGE DISTRIBUTION; ARTICLE; CELL VOLUME; CHILD; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALARIA CONTROL; MALARIA FALCIPARUM; MALE; PARASITOLOGY; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT FAILURE; TREATMENT OUTCOME; UGANDA;

EID: 0035806761     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(01)05557-X     Document Type: Article

References (31)

1. Challenges facing antimalarial therapy in Africa
2. Malaria disaster in Africa
3. Impact of chloroquine resistance on malarial mortality
4. Making malaria-treatment policy in the face of drug resistance
5. Averting a malaria disaster
6. An evaluation of five regimens for the outpatient therapy of falciparum malaria in Thailand 1980-81
7. High level of resistance of Plasmodium falciparum to sulfadoxine-pyrimethamine in children in Tanzania
8. Sensitivity of Plasmodium falciparum in vivo to chloroquine and pyrimethamine-sulfadoxine in Rwandan patients in a refugee camp in Zaire
9. A comparison of amodiaquine and sulfadoxine-pyrimethamine as first-line treatment of falciparum malaria in Kenya
10. Systematic review of amodiaquine treatment in uncomplicated malaria
11. Amodiaquine
12. Can amodiaquine be resurrected?
13. Amodiaquine remains effective for treating uncomplicated malaria in West and Central Africa
14. In vivo efficacy study of amodiaquine and sulfadoxine/pyrimethamine in Kibwezi, Kenya and Kigoma, Tanzania
15. Chloroquine or amodiaquine combined with sulfadoxine-pyrimethamine as a treatment for uncomplicated malaria - A systematic review
16. Predictors of chloroquine treatment failure in children and adults with falciparum malaria in Kampala, Uganda
17. The comparative efficacy of chloroquine and sulfadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in Kampala, Uganda
18. In vivo sensitivity of Plasmodium falciparum to chloroquine, amodiaquine, and sulfadoxine-pyrimethamine in Western Uganda
19. Severe and complicated malaria
20. Adaptations of the Saker-Solomons test: Simple reliable colorimetric field assays for chloroquine and its metabolites in urine
21. A randomized trial of chloroquine, amodiaquine and pyrimethamine-sulfadoxine in Gambian children with uncomplicated malaria
22. Early clinical failures after pyrimethamine-sulfadoxine treatment of uncomplicated falciparum malaria
23. A randomized controlled trial of artemether/benflumetol, a new antimalarial and pyrimethamine/sulfadoxine in the treatment of uncomplicated falciparum malaria in African children
24. Effects of artemisinin derivatives on malaria transmissibility
25. Serious adverse drug reactions to pyrimethamine-sulfadoxine, pyrimethamine-dapsone and to amodiaquine in Britain
26. Antimalarial drug resistance and combination chemotherapy
27. Epidemiology of drug resistance in malaria
28. Treatment of Plasmodium falciparum malaria with pyrimethamine-sulfadoxine: Selective pressure for resistance is a function of long elimination half-life
29. Pharmacokinetics of quinine, chloroquine, and amodiaquine: Clinical implications